ArticleMolecular therapy oncolytics2020

Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.

Feng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.